Entrada Therapeutics, Inc.
TRDA
$7.46
$0.010.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 223.01M | 254.86M | 295.70M | 326.84M | 354.01M |
| Total Receivables | 1.72M | 2.29M | 2.58M | 3.20M | 3.38M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.98M | 9.73M | 7.32M | 8.22M | 11.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 658.00K | -- | -- |
| Total Current Assets | 232.70M | 266.87M | 306.25M | 338.26M | 369.15M |
|
|
|||||
| Total Current Assets | 232.70M | 266.87M | 306.25M | 338.26M | 369.15M |
| Net Property, Plant & Equipment | 62.76M | 65.26M | 67.76M | 70.53M | 75.49M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.41M | 3.38M | 3.36M | 4.11M | 4.15M |
| Total Assets | 298.88M | 335.52M | 377.38M | 412.90M | 448.78M |
|
|
|||||
| Total Accounts Payable | 3.75M | 2.93M | 2.29M | 3.17M | 1.86M |
| Total Accrued Expenses | 12.33M | 11.00M | 16.51M | 14.81M | 11.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.45M | 4.28M | 4.14M | 4.35M | 5.46M |
| Total Finance Division Other Current Liabilities | 845.00K | 980.00K | 1.52M | 1.69M | 1.16M |
| Total Other Current Liabilities | 845.00K | 980.00K | 1.52M | 1.69M | 1.16M |
| Total Current Liabilities | 21.37M | 19.20M | 24.45M | 24.02M | 19.80M |
|
|
|||||
| Total Current Liabilities | 21.37M | 19.20M | 24.45M | 24.02M | 19.80M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 44.10M | 45.47M | 46.79M | 48.05M | 49.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 113.00K | 194.00K |
| Total Liabilities | 65.47M | 64.66M | 71.25M | 72.18M | 69.28M |
|
|
|||||
| Common Stock & APIC | 588.92M | 583.42M | 578.58M | 574.03M | 568.90M |
| Retained Earnings | -355.57M | -312.81M | -273.09M | -233.93M | -189.80M |
| Treasury Stock & Other | 66.00K | 246.00K | 652.00K | 621.00K | 400.00K |
| Total Common Equity | 233.41M | 270.85M | 306.13M | 340.72M | 379.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 233.41M | 270.85M | 306.13M | 340.72M | 379.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 233.41M | 270.85M | 306.13M | 340.72M | 379.51M |
|
|
|||||